Stellato Paul A 4

What Happened

• Paul A. Stellato, Vice President, Controller and Chief Accounting Officer of Zimmer Biomet (ZBH), was credited with 1,363 restricted stock units (RSUs) on Feb 19, 2026. The RSUs are reported as a derivative acquisition (grant) at $0.00 per unit and will vest on March 6, 2026. This was a compensation award (not a market purchase or sale).

Key Details

• Transaction date: 2026-02-19 (report filed 2026-02-23).
• Transaction type/code: Grant/Award (A).
• Amount: 1,363 RSUs; reported price $0.00 (derivative).
• Vesting: RSUs will vest on March 6, 2026.
• Shares owned after the transaction: not specified in this filing.
• Footnotes: (1) Each RSU represents a contingent right to receive one share of common stock. (2) These were performance-based RSUs originally granted on March 6, 2023 for the 2023–2025 performance period; the final number earned was determined Feb 19, 2026.
• Filing timeliness: Report shows filing date; no late-filing flag was indicated in the provided data.

Context

• This is a performance-based compensation award and is typically routine corporate compensation rather than a direct signal of insider buying or selling. Upon vesting, each RSU will convert into one share (subject to any withholding), at which point the insider may hold or sell those shares per usual insider-trading rules.